BRSYF — Brainsway Ltd.
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1505065 ·
Last close
$15.13
Market Cap
$608.35M
52W High
$16.84
52W Low
$5.49
ADV30
0
Next earnings
2026-11-10
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 17,107,000 | 12,766,000 | 2,391,000 | 2,710,000 | 121,975,000 | 62,108,000 | 42,786,000 |
| Mar 2026 | 15,531,000 | 11,675,000 | 2,005,000 | 2,290,000 | 116,998,000 | 58,636,000 | 41,201,000 |
| Dec 2025 | 14,545,000 | 11,118,000 | 1,916,000 | 2,933,000 | 112,917,000 | 67,700,000 | 39,696,000 |
| Sep 2025 | 13,512,000 | 10,159,000 | 1,253,000 | 1,566,000 | 113,062,000 | 70,458,000 | 42,997,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$14,181,000
Investing CF
$-24,854,000
Financing CF
$-2,360,000
CapEx
$-3,778,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$0.22
As of
2026-08-09
Balance + Analyst (yfinance extras)
Retained Earnings
$-88,516,000
Inventory
$7,078,000
Receivables
$7,530,000
ST Investments
$1,138,000
EBIT TTM
$10,961,000
Pretax Income TTM
$8,856,000
Interest Exp TTM
$2,105,000
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$60,695,000
EBITDA
$8,483,000
Free Cash Flow
$-6,157,500
Enterprise Value
$530,772,128
Total Cash
$62,108,000
Total Debt
$7,133,000
Shares Out
40,207,981
Trailing EPS
$0.23
Book Value
$2.04
ROE
12.8%
ROA
4.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 52,225,000 | 4,323,000 | 7,633,000 | 112,917,000 | 39,696,000 | 73,221,000 | 18,020,000 |
| Dec 2024 | 41,016,000 | 1,391,000 | 2,921,000 | 94,316,000 | 32,003,000 | 62,313,000 | 10,298,000 |
| Dec 2023 | 31,785,000 | -4,959,000 | -4,197,000 | 62,972,000 | 21,391,000 | 41,581,000 | 1,284,000 |
| Dec 2022 | 27,177,000 | -12,683,000 | -13,349,000 | 64,477,000 | 19,080,000 | 45,397,000 | -9,760,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$0.13
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SSII | SS Innovations International, Inc. | $591.14M | $2.95 | — |
| KIDS | ORTHOPEDIATRICS CORP | $588.78M | $22.55 | — |
| ANGO | ANGIODYNAMICS INC | $640.24M | $15.49 | — |
| MDXG | MIMEDX GROUP, INC. | $681.51M | $4.67 | — |
| DCTH | DELCATH SYSTEMS, INC. | $541.30M | $15.60 | — |
News headlines (Yahoo Finance, 1h cache)
BrainsWay’s (BWAY) Growth Streak Just Got Harder To Ignore
2026-09-11 02:56 · Yahoo
Are Options Traders Betting on a Big Move in Brainsway Stock?
2026-09-09 17:58 · Yahoo
BrainsWay Reports Promising Pilot Study Results in Patients with Depression and Comorbid Early-Stage Alzheimer’s Disease Treated with Deep TMS™
2026-09-08 11:30 · Yahoo
Wall Street Analysts See a 30.07% Upside in Brainsway (BWAY): Can the Stock Really Move This High?
2026-08-27 13:55 · Yahoo
BrainsWay Deep TMS™ Study Shows 70% Reduction in Patients Experiencing Suicidal Ideation
2026-08-27 11:30 · Yahoo
Brainsway (BWAY) Upgraded to Buy: Here's Why
2026-08-17 16:00 · Yahoo
Is Allogene Therapeutics (ALLO) Stock Outpacing Its Medical Peers This Year?
2026-08-17 13:40 · Yahoo
Brainsway Q2 Earnings Call Highlights
2026-08-13 09:02 · Yahoo
BrainsWay Ltd (BRSYF) (Q2 2026) Earnings Call Highlights: Revenue Surges 35% to $17. ...
2026-08-12 23:03 · Yahoo
BrainsWay Reports Second Quarter 2026 Financial Results and Operational Highlights
2026-08-12 11:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.